Exact Mass: 319.0432

Exact Mass Matches: 319.0432

Found 38 metabolites which its exact mass value is equals to given mass value 319.0432, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

ONO-2235; ONO 2235; ONO2235; Sorbistat

2-[5-(2-methyl-3-phenylprop-2-en-1-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid

C15H13NO3S2 (319.0337)

6-Hydroxydelphinidin

3,5,6,7-Tetrahydroxy-2-(3,4,5-trihydroxyphenyl)-flavylium

C15H11O8 (319.0454)

ZINC4324866

ZINC4324866

C12H15Cl2N3O3 (319.049)

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)

Hernandonine

Hernandonine

C18H9NO5 (319.0481)

An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .

CHEMBL3182641

CHEMBL3182641

C15H13NO3S2 (319.0337)

Cassameridine

Cassameridine

C18H9NO5 (319.0481)

An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.

Epalrestat

Epalrestat

C15H13NO3S2 (319.0337)

C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors

MMV676383

MMV676383

C14H13N3O2S2 (319.0449)

Cetophenicol

Acetamide,N-[(1R,2R)-2-(4-acetylphenyl)-2-hydroxy-1-(hydroxymethyl)ethyl]-2,2-dichloro-

C13H15Cl2NO4 (319.0378)

C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride

C12H19BrClN3 (319.0451)

6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

C16H8F3NO3 (319.0456)

2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid

2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid

C13H15Cl2NO4 (319.0378)

Bupropion hydrobromide

Bupropion hydrobromide

C13H19BrClNO (319.0338)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one

4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one

C15H11ClFN3O2 (319.0524)

3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile

3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile

C15H8F3N3S (319.0391)

CNP-AFU

CNP-AFU

C12H14ClNO7 (319.0459)

Diphenylammonium trifluoromethanesulfonate

Diphenylammonium trifluoromethanesulfonate

C13H12F3NO3S (319.049)

5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)

5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)

7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile

7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile

C17H9N3O2S (319.0415)

5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde

5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde

C14H7F6NO (319.0432)

N-(4-Chlorobenzoyloxy)-4-nitrobenzimidamide

[[Amino-(4-nitrophenyl)methylidene]amino] 4-chlorobenzoate

C14H10ClN3O4 (319.036)

1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)

1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)

C13H19BrClNO (319.0338)

n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride

n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride

C13H19BrClNO (319.0338)

4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline

4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline

C15H11ClFN3O2 (319.0524)

OCTYL RESIN

OCTYL RESIN

C13H9N3O7 (319.044)

FAAH-IN-2

4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol

C15H11ClFN3O2 (319.0524)

FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.

2-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid

2-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid

C15H13NO3S2 (319.0337)

2-Acetylaminofluorene-N-sulfate

2-Acetylaminofluorene-N-sulfate

C15H13NO5S (319.0514)

N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide

N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide

C14H13N3O2S2 (319.0449)

(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate

(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate

C15H11O8- (319.0454)

N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide

N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide

C14H13N3O2S2 (319.0449)

6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole

6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole

C16H14FNOS2 (319.0501)

N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide

N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide

C11H14ClN3O4S (319.0394)

(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)

N-(2,4-Dichloro-5-(2-hydroxyethoxy)phenoxycarbonyl)tetrahydropyrrole

N-(2,4-Dichloro-5-(2-hydroxyethoxy)phenoxycarbonyl)tetrahydropyrrole

C13H15Cl2NO4 (319.0378)

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(22),2,4(8),9,12(23),13,15,17-octaen-11-one

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(22),2,4(8),9,12(23),13,15,17-octaen-11-one

C18H9NO5 (319.0481)